RSS   Newsletter   Contact   Advertise with us
Post Online Media

Avillion expands leadership team

Share on Twitter Share on LinkedIn
Staff writer | London, United Kingdom |
Ramani VaranasiMay 29, 2013, London, United Kingdom - Avillion LLP, a drug development company, announced the appointment of Ramani Varanasi as chief business officer.
Ms. Varanasi is an accomplished business executive, bringing more than 18 years of biotechnology and pharmaceutical industry experience to Avillion. She has a distinguished track record in structuring, negotiating and executing successful strategic alliances, licensing agreements and M&A transactions as well as providing business development, management and strategic leadership to organisations.

Over her career, Ms. Varanasi has held research and senior level positions in business & corporate development including at Merck, Millennium/Takeda, Momenta Pharmaceuticals, Archemix and RXi Pharmaceuticals. She holds a BSc and an MSc from McGill University in Microbiology & Immunology and Biochemistry, respectfully, and an MBA in General Strategy from Northeastern University.

 LATEST MOVES FROM United Kingdom 

POST Online Media Contact